Natural resistance to cancers: a Darwinian hypothesis to explain Peto's paradox

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Roche, Benjamin ^a,h   Hochberg, Michael E ^b,c,h   Caulin, Aleah F ^d   Maley, Carlo C ^e   Gatenby, Robert A ^f   Misse, Dorothée ^g,h   Thomas, Frédéric ^g,h  

^a SORBONNE UNIVERSITÉ   (France)

^b INSTITUT DES SCIENCES DE L EVOLUTION   (France)

^c SANTA FE INSTITUTE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^g CNRS   (France)

^h Universite de Montpellier   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CANCER RESEARCH; CANCER RESISTANCE; CANCER RISK; ENVIRONMENTAL FACTOR; GENE FREQUENCY; GENOME ANALYSIS; HUMAN; MOLECULAR EVOLUTION; NONHUMAN; ONCOGENE; PETO PARADOX; PREDICTION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; THEORY; TUMOR SUPPRESSOR GENE; WILDLIFE;

ANIMALS; BIOLOGICAL EVOLUTION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; IMMUNITY, INNATE; MODELS, THEORETICAL; NEOPLASMS; SELECTION, GENETIC;

EID: 84868340054     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-387     Document Type: Article

References (21)

1. Greaves M. Darwinian medicine: a case for cancer. Nature Rev Canc 2007, 7:213-221.
2. Caulin AF, Maley CC. Peto's paradox: evolution's prescription for cancer prevention. TREE 2011, 26:175-182. 3060950, 21296451.
3. Peto R, Roe FJ, Lee PN, Levy L, Clack J. Cancer and ageing in mice and men. Br J Cancer 1975, 32:411-426. 10.1038/bjc.1975.242, 2024769, 1212409.
4. Albanes D, Winic M. Are cell number and cell proliferation risk factors for cancer?. JNCI J Natl Cancer Inst 1988, 80(10):772-775.
5. Diekmann O. A beginner's guide to adpative dynamics. Banach Center Publ 2003, 63:47-86.
6. Hardison RC. Comparative genomics. PLoS Biol 2003, 1(2):e58. 261895, 14624258.
7. Calabrese P, Shibata D. A simple algebric cancer équation: calculating how cancers may arise with normal mutation rates. BMC Cancer 2010, 10:3. 10.1186/1471-2407-10-3, 2829925, 20051132.
8. Walker B, Figgs LW, Zahm SH. Differences in cancer incidence, mortality and survival between African Americans and whites. Environ Health Perpect 1995, 103(Suppl 8):275-281.
9. Le Souëf PN, Goldblatt J, Lynch NR. Evolutionary adaptation of inflammatory immune responses in human beings. Lancet 2000, 356:242-244. 10.1016/S0140-6736(00)02491-0, 10963213.
10. O'Byrne KJ, Dalgleish AG. Evolution, immune response, and cancer. Lancet 2000, 356:1033.
11. Maley CC, Forrest S. Exploring the relationship between neutral and selective mutations in cancer. Artif Life 2000, 6(4):325-345. 10.1162/106454600300103665, 11348585.
12. Luebeck EG, Moolgavkar SH. Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci U S A 2002, 99(23):15095-15100. 10.1073/pnas.222118199, 137549, 12415112.
13. Nunney L. The population genetics of multistage carcinogenesis. Proc Biol Sci 2003, 270(1520):1183-1191. 10.1098/rspb.2003.2351, 1691357, 12816658.
14. Calabrese P, Tavare S, Shibata D. Pretumor progression: clonal evolution of human stem cell populations. Am J Pathol 2004, 64(4):1337-1346.
15. Beerenwinkel N, Antal T, Dingli D, Traulsen A, Kinzler KW, Velculescu VE, Volgestein B, Nowak MA. Genetic progression and the waiting time to cancer. PLoS Comput Biol 2007, 3(11):e225. 10.1371/journal.pcbi.0030225, 2065895, 17997597.
16. Meza R, Jeon J, Moolgavkar SH, Luebeck EG. Age-specific incidence of cancer: phases, transitions, and biological implications. Proc Natl Acad Sci U S A 2008, 105(42):16284-16289. 10.1073/pnas.0801151105, 2570975, 18936480.
17. Maley CC, Lewis W, Reid BJ. Has cancer sculpted the genome?. Modeling linkage and the role of tetraploidy in neoplastic progression. in Multiscale Cancer Modeling 2010, Boca Raton, FL: Chapman & Hall/CRC Press, Deisbock T, Stamakos GS.
18. Sprouffske K, Pepper JW, Maley CC. Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prevention Research 2011, 4(7):1135-1144. 10.1158/1940-6207.CAPR-10-0374, 3131446, 21490131.
19. Gatenby RA, Maini PK. Mathematical oncology: cancer summed up. Nature 2003, 421:321. 10.1038/421321a, 12540881.
20. Silva AS, Gatenby RA. A theoretical quantitative model for evolution of cancer chemotherapy resistance. Biol Direct 2010, 5:25. 10.1186/1745-6150-5-25, 2868834, 20406443.
21. McAloose D, AL N. Wildlife cancer: a conservation perspective. Nature Rev Canc 2009, 9:517-526.